A numerically greater percentage of patients in the Diabetes subgroup compared to those in the No Diabetes subgroup were receiving oral iron (36.8% vs 28.6%), statin (50.0% vs 34.9%), anti-diabetic agent (69.1% vs 0) including insulin (39.7% vs 1.6%), or diuretic (58.8% vs 38.1%) through Week 52 (Online Resource 1). The gene discussed is INS; the disease is diabetes mellitus.